Company intelligence / Profile preview
Oasis Biotechnology
Suzhou, Jiangsu, Chinaoasis-bio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Oasis Biotechnology is a clinical-stage biopharmaceutical company focused on developing innovative RNA interference (RNAi) therapeutics. Based in Suzhou, China, the company leverages its proprietary GalNAc-siRNA delivery platform to target chronic diseases with high unmet medical needs, particularly in the cardiovascular and metabolic spaces. Their pipeline includes candidates for hyperlipidemia, hypertension, and chronic hepatitis B infection. Oasis aims to provide long-acting, highly specific treatments that improve patient compliance and outcomes compared to traditional small molecule therapies. The company is backed by leading venture capital firms including Matrix Partners China and GL Ventures.
- Therapeutic areas
- Infectious DiseasesCardiovascular
- Modalities
- Small interfering RNABiologicRNA therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Oasis Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oasis Biotechnology.